Foundation Medicine announced today that it has formed a three-way collaboration with Horizon Healthcare Services and Clinical Outcomes Tracking

Illumina and China's Novogene today announced an agreement to jointly develop next-generation sequencing applications for reproductive health and oncology.

As a new type of genetic testing technology, Gene Sequencing analyzes and tests complete gene sequencing through blood or ptysma which can forecast the possibility of personal diseases and different kinds of behaviora..

The American Heart Association (AHA), Verily (formerly Google Life Sciences) and AstraZeneca ($AZN) have chipped in a total of $75 million over 5 years to support "one brave idea from a visionary leader" to cure coronary heart disease.

Thermo Fisher Scientific said after the close of the market Friday that it is acquiring Affymetrix for approximately $1.3 billion.

Lepu Medical Technologies announced recently to prepare the big issue of acquisition with estimated amount of ￥650 million to ￥1.2 billion and the acquisition target embraced cardiovascular drug enterprises and hospitals.

Now 2016 has come, but for Theranos, which was just revealed a serious fraud technically in 2015, the new year doesn’t seem good.

NeoGenomics said today it has agreed to acquire Clarient and its wholly-owned subsidiary Clarient Diagnostic Services from GE Healthcare.

Jan medical, which is located in Mountain View, California, recently has raised $ 7.5 million from Germany, Brain lab medical company as the cost of the research and development of the diagnosis connected devices for nervous system diseases.

Recently, US pharmaceutical giant Abbott announced their acquisition of Alere Inc at the price of $56 per share, spending a total of $5.8 billion.

10x Genomics has entered into collaborations with Illumina ($ILMN), Agilent Technologies ($A) and Qiagen ($QGEN).

Recently, Invivoscribe Technologies announced that it has formed a strategic partnership with Thermo Fisher Scientific to develop multiple next-generation sequencing-based in vitro cancer diagnostics.

Livzon Pharmaceutical recently announced that its holding subsidiary Zhuhai Livzon Diagnostics Inc.

DNA construction firm Gen9 and British synthetic biology network SynbiCite have announced a partnership to increase access to gene synthesis technology.

Children's Hospital Los Angeles and Thermo Fisher Scientific announced today that they will partner to develop a next-generation sequencing-based gene panel for pediatric cancer research.